(OLED) Universal Display - Overview
Stock: Phosphorescent, OLED, Materials, Licensing, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.30% |
| Yield on Cost 5y | 0.80% |
| Yield CAGR 5y | 22.47% |
| Payout Consistency | 100.0% |
| Payout Ratio | 48.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 45.3% |
| Relative Tail Risk | -6.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.20 |
| Alpha | -38.64 |
| Character TTM | |
|---|---|
| Beta | 1.626 |
| Beta Downside | 1.591 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.57% |
| CAGR/Max DD | -0.03 |
Description: OLED Universal Display January 07, 2026
Universal Display Corporation (NASDAQ:OLED) develops and licenses OLED technologies and materials, most notably its phosphorescent “UniversalPHOLED” platform, which underpins high-efficiency displays and solid-state lighting. The firm also commercializes flexible-OLED (FOLED) processes and organic vapor-jet printing (OVJP), and offers contract research, IP licensing, and third-party support services across a global footprint that includes South Korea, China, Japan, and the United States.
Key industry metrics that drive OLED demand include the rapid rollout of 5G smartphones-where OLED panels now capture roughly 70% of premium handset shipments-and the accelerating adoption of OLED TV panels, which grew at a compound annual growth rate (CAGR) of ~15% from 2020-2023. Automotive OEMs are also expanding OLED lighting and instrument clusters, adding a secular growth tail. Universal Display’s FY 2024 revenue rose 12% YoY to $1.1 billion, with its licensing royalties representing ~55% of total earnings, reflecting the high-margin nature of its IP model. However, the company’s exposure to supply-chain constraints for high-purity emitters and the competitive push from micro-LED technologies remain material risks.
For a deeper quantitative analysis, you may want to explore ValueRay’s detailed model on OLED.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 221.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -3.78 > 1.0 |
| NWC/Revenue: 145.1% < 20% (prev 125.9%; Δ 19.17% < -1%) |
| CFO/TA 0.11 > 3% & CFO 214.4m > Net Income 221.7m |
| Net Debt (-101.3m) to EBITDA (290.4m): -0.35 < 3 |
| Current Ratio: 9.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.7m) vs 12m ago 0.02% < -2% |
| Gross Margin: 75.80% > 18% (prev 0.77%; Δ 7502 % > 0.5%) |
| Asset Turnover: 34.06% > 50% (prev 35.55%; Δ -1.49% > 0%) |
| Interest Coverage Ratio: -8.55 > 6 (EBITDA TTM 290.4m / Interest Expense TTM -28.6m) |
Altman Z'' 10.00
| A: 0.48 (Total Current Assets 1.04b - Total Current Liabilities 108.6m) / Total Assets 1.95b |
| B: 0.54 (Retained Earnings 1.05b / Total Assets 1.95b) |
| C: 0.13 (EBIT TTM 244.8m / Avg Total Assets 1.88b) |
| D: 5.17 (Book Value of Equity 1.05b / Total Liabilities 202.6m) |
| Altman-Z'' Score: 11.18 = AAA |
Beneish M -3.16
| DSRI: 0.85 (Receivables 74.2m/87.7m, Revenue 640.0m/643.7m) |
| GMI: 1.02 (GM 75.80% / 77.14%) |
| AQI: 0.96 (AQ_t 0.35 / AQ_t-1 0.36) |
| SGI: 0.99 (Revenue 640.0m / 643.7m) |
| TATA: 0.00 (NI 221.7m - CFO 214.4m) / TA 1.95b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of OLED shares?
Over the past week, the price has changed by +5.48%, over one month by -4.19%, over three months by -10.17% and over the past year by -14.83%.
Is OLED a buy, sell or hold?
- StrongBuy: 4
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OLED price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 163.7 | 35.1% |
| Analysts Target Price | 163.7 | 35.1% |
| ValueRay Target Price | 121.2 | 0.1% |
OLED Fundamental Data Overview February 03, 2026
P/E Forward = 19.802
P/S = 8.5297
P/B = 3.1883
P/EG = 1.2266
Revenue TTM = 640.0m USD
EBIT TTM = 244.8m USD
EBITDA TTM = 290.4m USD
Long Term Debt = 20.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.05m USD (from shortTermDebt, two quarters ago)
Debt = 20.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -101.3m USD (from netDebt column, last quarter)
Enterprise Value = 4.88b USD (5.46b + Debt 20.4m - CCE 603.0m)
Interest Coverage Ratio = -8.55 (Ebit TTM 244.8m / Interest Expense TTM -28.6m)
EV/FCF = 30.22x (Enterprise Value 4.88b / FCF TTM 161.3m)
FCF Yield = 3.31% (FCF TTM 161.3m / Enterprise Value 4.88b)
FCF Margin = 25.21% (FCF TTM 161.3m / Revenue TTM 640.0m)
Net Margin = 34.64% (Net Income TTM 221.7m / Revenue TTM 640.0m)
Gross Margin = 75.80% ((Revenue TTM 640.0m - Cost of Revenue TTM 154.9m) / Revenue TTM)
Gross Margin QoQ = 71.20% (prev 77.18%)
Tobins Q-Ratio = 2.50 (Enterprise Value 4.88b / Total Assets 1.95b)
Interest Expense / Debt = 30.77% (Interest Expense 6.26m / Debt 20.4m)
Taxrate = 18.68% (10.1m / 54.1m)
NOPAT = 199.1m (EBIT 244.8m * (1 - 18.68%))
Current Ratio = 9.55 (Total Current Assets 1.04b / Total Current Liabilities 108.6m)
Debt / Equity = 0.01 (Debt 20.4m / totalStockholderEquity, last quarter 1.74b)
Debt / EBITDA = -0.35 (Net Debt -101.3m / EBITDA 290.4m)
Debt / FCF = -0.63 (Net Debt -101.3m / FCF TTM 161.3m)
Total Stockholder Equity = 1.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.80% (Net Income 221.7m / Total Assets 1.95b)
RoE = 13.17% (Net Income TTM 221.7m / Total Stockholder Equity 1.68b)
RoCE = 14.37% (EBIT 244.8m / Capital Employed (Equity 1.68b + L.T.Debt 20.4m))
RoIC = 11.82% (NOPAT 199.1m / Invested Capital 1.68b)
WACC = 11.96% (E(5.46b)/V(5.48b) * Re(11.91%) + D(20.4m)/V(5.48b) * Rd(30.77%) * (1-Tc(0.19)))
Discount Rate = 11.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.06%
[DCF Debug] Terminal Value 54.74% ; FCFF base≈184.2m ; Y1≈120.9m ; Y5≈55.2m
Fair Price DCF = 15.82 (EV 650.9m - Net Debt -101.3m = Equity 752.2m / Shares 47.5m; r=11.96% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -24.57 | EPS CAGR: -46.76% | SUE: -4.0 | # QB: 0
Revenue Correlation: 36.93 | Revenue CAGR: -1.23% | SUE: -2.89 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.26 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=5
EPS next Year (2026-12-31): EPS=5.54 | Chg30d=-0.057 | Revisions Net=-1 | Growth EPS=+12.0% | Growth Revenue=+10.9%